Grant: Collaborative Research and Development Grants
University of Saskatchewan
$38,470.00
Prevention of Inclusion Body Hepatitis (IBH) in the broiler Chicken Industry: Optimizing Two Prototype Fowl Adenoviral Vaccines
EF 2012-13
Résumé
Inclusion body hepatitis (IBH) is an acute viral disease in chickens characterized by sudden onset of high mortality with severe hepatic necrosis with microscopic intranuclear inclusion bodies. IBH is caused by several different serotypes of fowl adenoviruses (FAdV). Since 2000, IBH has emerged as the number one economically important disease for the broiler chicken industry in Canada. Although Saskatchewan has only 4% of the Canadian broiler chicken industry sales, it loses over $300,000/year due to mortality from IBH. Hence, the total Canadian broiler industry loss of productivity is much higher, estimated in millions of dollars. We were able to identify that outbreaks of IBH in Canada are primarily due to vertical transmission of FAdVs from their parents. We were also able to demonstrate that five major serotypes of FAdVs cause IBH across Canada and there is a significant protection of broilers against IBH by vaccinating broiler breeders with either inactivated or live FAdV vaccine. Although, we were able to produce two prototype vaccines against IBH with financial support from industry and NSERC, we need to optimize these inactivated and live FAdV vaccines to improve their efficacy before they can be manufactured and become commercially available to the broiler industry in Canada. This proposed research will optimize both live and inactivated FAdV vaccines, and improve our understanding of FAdV shedding and mutational changes of FAdV at the molecular level.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
428582-2011
Name nom
Gomis, Susantha
Department département
Western College of Veterinary Medicine
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
38470
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
1
Nb partie
4
Application title
Prevention of Inclusion Body Hepatitis (IBH) in the broiler Chicken Industry: Optimizing Two Prototype Fowl Adenoviral Vaccines
Keyword
NSERC
Application summary
Inclusion body hepatitis (IBH) is an acute viral disease in chickens characterized by sudden onset of high mortality with severe hepatic necrosis with microscopic intranuclear inclusion bodies. IBH is caused by several different serotypes of fowl adenoviruses (FAdV). Since 2000, IBH has emerged as the number one economically important disease for the broiler chicken industry in Canada. Although Saskatchewan has only 4% of the Canadian broiler chicken industry sales, it loses over $300,000/year due to mortality from IBH. Hence, the total Canadian broiler industry loss of productivity is much higher, estimated in millions of dollars. We were able to identify that outbreaks of IBH in Canada are primarily due to vertical transmission of FAdVs from their parents. We were also able to demonstrate that five major serotypes of FAdVs cause IBH across Canada and there is a significant protection of broilers against IBH by vaccinating broiler breeders with either inactivated or live FAdV vaccine. Although, we were able to produce two prototype vaccines against IBH with financial support from industry and NSERC, we need to optimize these inactivated and live FAdV vaccines to improve their efficacy before they can be manufactured and become commercially available to the broiler industry in Canada. This proposed research will optimize both live and inactivated FAdV vaccines, and improve our understanding of FAdV shedding and mutational changes of FAdV at the molecular level.